Publications
- Treatment of ALK positive non-small cell lung cancer2021 | First Faculty of Medicine
- Impact of Concomitant Medication Administered at the Time of Initiation of Nivolumab Therapy on Outcome in Non-small Cell Lung Cancer2020 | First Faculty of Medicine, Third Faculty of Medicine, Faculty of Medicine in Pilsen, Faculty of Medicine in Hradec Králové
- Targeted treatment of bronchogenic carcinoma2020 | First Faculty of Medicine
- Clinical dilemma of lung cancer treatment with anti-PD-1 therapy (nivolumab) in the discovery of rheumatological problems with joint swelling - case report2020 | First Faculty of Medicine
- Lorlatinib in the treatment of non-small cell lung cancer2020 | First Faculty of Medicine
- Targeted therapy in pulmonary medicine2016 | First Faculty of Medicine
- Serious Immune-related Adverse Events Are Associated With Greater Efficacy of Nivolumab Therapy Against Non-small Cell Lung Cancer2023 | Third Faculty of Medicine, Faculty of Medicine in Pilsen, Faculty of Medicine in Hradec Králové, Central Library of Charles University
- Klinická onkologie2023 | First Faculty of Medicine, Second Faculty of Medicine, Third Faculty of Medicine, Faculty of Medicine in Pilsen
- Léčba pokročilého a metastazujícího nemalobuněčného karcinomu plic bez řídicích mutací2023 | First Faculty of Medicine
- Chest pain2022 | First Faculty of Medicine, Second Faculty of Medicine, Central Library of Charles University
Loading network view...